- PDB-2y7x: The discovery of potent and long-acting oral factor Xa inhibitors... -
+
データを開く
IDまたはキーワード:
読み込み中...
-
基本情報
登録情報
データベース: PDB / ID: 2y7x
タイトル
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs
要素
ACTIVATED FACTOR XA HEAVY CHAIN
FACTOR X LIGHT CHAIN
キーワード
BLOOD CLOTTING / HYDROLASE / SERINE PROTEASE
機能・相同性
機能・相同性情報
coagulation factor Xa / Defective factor IX causes thrombophilia / Defective cofactor function of FVIIIa variant / Defective F9 variant does not activate FX / Extrinsic Pathway of Fibrin Clot Formation / positive regulation of TOR signaling / Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus / Gamma-carboxylation of protein precursors / Common Pathway of Fibrin Clot Formation / Removal of aminoterminal propeptides from gamma-carboxylated proteins ...coagulation factor Xa / Defective factor IX causes thrombophilia / Defective cofactor function of FVIIIa variant / Defective F9 variant does not activate FX / Extrinsic Pathway of Fibrin Clot Formation / positive regulation of TOR signaling / Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus / Gamma-carboxylation of protein precursors / Common Pathway of Fibrin Clot Formation / Removal of aminoterminal propeptides from gamma-carboxylated proteins / Intrinsic Pathway of Fibrin Clot Formation / phospholipid binding / Golgi lumen / blood coagulation / positive regulation of cell migration / endoplasmic reticulum lumen / serine-type endopeptidase activity / external side of plasma membrane / calcium ion binding / proteolysis / extracellular space / extracellular region / plasma membrane 類似検索 - 分子機能
SHEET DETERMINATION METHOD: DSSP THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS BELOW ... SHEET DETERMINATION METHOD: DSSP THE SHEETS PRESENTED AS "AB" IN EACH CHAIN ON SHEET RECORDS BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS ARE IDENTICAL.
ACTIVATEDFACTORXAHEAVYCHAIN / COAGULATION FACTOR X / STUART FACTOR / STUART-PROWER FACTOR
分子量: 28550.596 Da / 分子数: 1 / 由来タイプ: 天然 詳細: PURCHASED FROM ENZYME RESEARCH LABS. ISOLATED FROM HUMAN BLOOD 由来: (天然) HOMO SAPIENS (ヒト) / 参照: UniProt: P00742, coagulation factor Xa
#2: タンパク質
FACTORXLIGHTCHAIN / COAGULATION FACTOR X / STUART FACTOR / STUART-PROWER FACTOR
分子量: 15210.793 Da / 分子数: 1 / Fragment: ACTIVATED DESGLA, RESIDUES 46-179 / 由来タイプ: 天然 詳細: PURCHASED FROM ENZYME RESEARCH LABS. ISOLATED FROM HUMAN BLOOD 由来: (天然) HOMO SAPIENS (ヒト) / 参照: UniProt: P00742, coagulation factor Xa
プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
波長: 1.5418 Å / 相対比: 1
反射
解像度: 1.9→45.47 Å / Num. obs: 24069 / % possible obs: 94.8 % / Observed criterion σ(I): 0 / 冗長度: 3.82 % / Biso Wilson estimate: 31.034 Å2 / Rmerge(I) obs: 0.05 / Net I/σ(I): 16.8
反射 シェル
解像度: 1.9→1.97 Å / 冗長度: 3.81 % / Rmerge(I) obs: 0.32 / Mean I/σ(I) obs: 4 / % possible all: 90.5
-
解析
ソフトウェア
名称
バージョン
分類
REFMAC
5.5.0109
精密化
d*TREK
データ削減
d*TREK
データスケーリング
精密化
構造決定の手法: OTHER 開始モデル: NONE 解像度: 1.9→20 Å / Cor.coef. Fo:Fc: 0.959 / Cor.coef. Fo:Fc free: 0.935 / SU B: 3.523 / SU ML: 0.103 / 交差検証法: THROUGHOUT / ESU R: 0.159 / ESU R Free: 0.147 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. SOME RESIDUES IN CHAIN ARE NOT SEEN IN THE ELECTRON DENSITY.
Rfactor
反射数
%反射
Selection details
Rfree
0.22952
1230
5.1 %
RANDOM
Rwork
0.18555
-
-
-
obs
0.18772
22823
100 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.4 Å / 溶媒モデル: BABINET MODEL WITH MASK